BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 10, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 7, 2015
View Archived Issues
Eisai reflects on accomplishments of first quarter of fiscal 2015
Read More
Oasmia reports results for Paclical compared to Abraxane in metastatic breast cancer
Read More
ProtoKinetix updates on studies on AAGP in pancreatic islet transplantation
Read More
New cell-based BBB model for studying drug transport in AD
Read More
FDA awards orphan drug status to Insys's cannabidiol for infantile spasms
Read More
Karuna Pharmaceuticals receives Wellcome Trust funding to develop KarXT for schizophrenia
Read More
Ultragenyx begins phase II study of recombinant human beta-glucuronidase
Read More
Vtesse reports preliminary data from ongoing phase I study of VTS-270
Read More
Enrollment begins in U.S. phase III trial of ECCS-50
Read More
Theravance Biopharma receives FDA fast track designation for TD-8954
Read More
InMed Pharmaceuticals reports in vitro study results for INM-750
Read More
Pseudo-glycodendrimer blocks HIV transinfection
Read More
GW Pharmaceuticals receives FDA fast track and EMA orphan status for intravenous cannabidiol
Read More
GSK initiates first-in-human study of RSV vaccine GSK-3389245A
Read More
Promising antiatherosclerosis activity of human FOXP3 gene therapy in mice
Read More
Immunotherapy collaboration between Juno Therapeutics and Celgene becomes effective
Read More
Apodemus AB patents antivirals
Read More
Egis Pharmaceuticals discloses dual GABA(A) agonist/antagonists
Read More
Advaxis receives prostate cancer charity grants to develop ADXS-PSA
Read More
Aerie forms ophthalmic delivery collaboration with GrayBug
Read More
Marathon discloses plans for NDA of deflazacort for Duchenne muscular dystrophy
Read More
FORUM Pharmaceuticals synthesizes gamma-secretase modulators
Read More
Cleave Biosciences reports development of p97 complex inhibitors
Read More
Dicerna's DCR-PH1 receives orphan drug designation from the EMA
Read More
FDA approves IND application for Valor's IGN-002
Read More
TiGenix and FDA agree design for phase III trial of Cx-601 in perianal fistula
Read More
Gammaplex approved for use in pediatric patients
Read More
Keystone Nano awarded NIAID contract to develop RNAi therapeutic for influenza
Read More
